Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/16/2025

Hemoglobin Threshold for Transfusion in Sickle Cell Disease

Context-Specific Transfusion Thresholds

  • The American Society of Hematology recommends initiating simple transfusion when hemoglobin falls below 9 g/dL, targeting a post-transfusion hemoglobin of 9-11 g/dL, while avoiding exceeding 11 g/dL to prevent hyperviscosity in sickle cell disease patients 1, 2
  • For low- to moderate-risk surgery, transfuse when pre-operative hemoglobin is <9 g/dL, targeting 9-11 g/dL, as recommended by the American College of Surgeons 1, 2
  • The American College of Cardiology recommends using simple transfusion for baseline hemoglobin <9 g/dL and considering exchange transfusion if baseline hemoglobin is 9-10 g/dL or higher to avoid hyperviscosity in high-risk surgery patients 1, 2
  • The target hemoglobin should be around 10 g/dL for patients undergoing surgery, according to the American Society of Anesthesiologists 3, 4, 5, 6
  • For high-risk surgery, exchange transfusion is preferred regardless of baseline hemoglobin, with a target post-transfusion hemoglobin of 10-11 g/dL and HbS <30%, as recommended by the American Heart Association 1, 2, 3, 4

Critical Safety Parameters

  • The American Society of Hematology recommends never exceeding post-transfusion hemoglobin of 11 g/dL to avoid hyperviscosity in sickle cell disease patients 1, 2
  • Do not increase hemoglobin by more than 4 g/dL in a single transfusion episode, as recommended by the American College of Physicians 3, 4, 5, 6
  • Patients with HbSC disease may have baseline hemoglobin up to 12 g/dL; in these cases, partial exchange transfusion to lower HbS% may allow slightly higher target hemoglobin >10 g/dL, according to the American Society of Hematology 3, 4
  • All transfused blood must be HbS-negative, as recommended by the American Association of Blood Banks 3, 4, 5, 6
  • Match for ABO, full Rh, and Kell antigens at minimum to reduce alloimmunization risk, as recommended by the American Society of Clinical Oncology 3, 4, 5, 6
  • Monitor for delayed hemolytic transfusion reactions, particularly in patients with history of alloimmunization or DHTR, as recommended by the American Society of Hematology 1
  • Avoid over-transfusion in patients with higher baseline hemoglobin, particularly those with HbSC disease, and use exchange transfusion rather than simple transfusion in these patients, as recommended by the American College of Physicians 3, 4